Shirleen buys PCYC 104.5: Medivation Significantly Undervalued, With Xtandi Weeks Away From Prostate Cancer Label Expansion
The best two examples are Pharmacyclics (NASDAQ:PCYC), which markets the blood cancer drug Imbruvica, and Incyte (NASDAQ:INCY), which markets the Myelofibrosis drug Jakafi, having enterprise values of $6.4 billion and $8.1 billion respectively. All three . ... ...
56 people liked this
0 Comments:
Post a Comment
Subscribe to Post Comments [Atom]
<< Home